Technical Analysis for PEN - Penumbra, Inc.

Grade Last Price % Change Price Change
grade C 166.49 -0.16% -0.27
PEN closed down 0.16 percent on Monday, November 18, 2019, on 60 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Flat
See historical PEN trend table...

Date Alert Name Type % Chg
MACD Bearish Signal Line Cross Bearish 0.00%
Golden Cross Bullish -0.16%
Calm After Storm Range Contraction -0.16%
Narrow Range Bar Range Contraction -0.16%
NR7 Range Contraction -0.16%
Calm After Storm Range Contraction 1.00%
Down 3 Days in a Row Weakness 1.00%
Calm After Storm Range Contraction 0.28%
Narrow Range Bar Range Contraction 0.28%
NR7 Range Contraction 0.28%

Older signals for PEN ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in United States, Japan, and internationally. The company offers neurovascular access products under the Neuron, Neuron MAX, Select, BENCHMARK, DDC, PXSLIM, and Velocity brands; and aspiration-based thrombectomy systems and accessory devices under the Penumbra System brand, as well as stent retriever for mechanical thrombectomy under the 3D brand. It also provides neurovascular embolization coiling systems to treat patients with various sizes of aneurysms and other neurovascular lesions under the Penumbra Coil 400 and Penumbra SMART Coil brands, as well as neurovascular stents under the LIBERTY Stent brand; neurosurgical tools for the removal of tissue and fluids under the Apollo System brand; detachable embolic coil systems for peripheral embolization under the RUBY Coil brand; detachable, microcatheter-deliverable occlusion devices under the POD (penumbra occlusion device) brand; and aspiration-based thrombectomy systems for peripheral applications under the Indigo System brand. The company sells its products through its salesforce and distributors to hospitals in the neuro and peripheral vascular markets. Penumbra, Inc. was founded in 2004 and is headquartered in Alameda, California.
Medicine Health Health Care Interventional Radiology Stent Markets Medical Devices Aneurysm
Is PEN a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 0 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 185.7
52 Week Low 110.84
Average Volume 605,190
200-Day Moving Average 150.0783
50-Day Moving Average 150.775
20-Day Moving Average 161.58
10-Day Moving Average 166.68
Average True Range 5.2378
ADX 24.64
+DI 28.6577
-DI 18.3171
Chandelier Exit (Long, 3 ATRs ) 159.8066
Chandelier Exit (Short, 3 ATRs ) 159.7034
Upper Bollinger Band 174.1909
Lower Bollinger Band 148.9691
Percent B (%b) 0.69
BandWidth 15.609481
MACD Line 5.0301
MACD Signal Line 5.1811
MACD Histogram -0.151
Fundamentals Value
Market Cap 5.63 Billion
Num Shares 33.8 Million
EPS 0.15
Price-to-Earnings (P/E) Ratio 1109.93
Price-to-Sales 11.15
Price-to-Book 8.79
PEG Ratio -71.69
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 171.20
Resistance 3 (R3) 171.63 170.50 170.42
Resistance 2 (R2) 170.50 169.30 170.28 170.15
Resistance 1 (R1) 168.49 168.56 167.93 168.06 169.89
Pivot Point 167.36 167.36 167.07 167.14 167.36
Support 1 (S1) 165.35 166.16 164.79 164.92 163.09
Support 2 (S2) 164.22 165.42 164.00 162.83
Support 3 (S3) 162.21 164.22 162.57
Support 4 (S4) 161.78